Buflomedil HCl Injection

• Post Date:

  Dec 23,2024

• Expiry Date:

  Jun 21,2025

• Detailed Description:

  Cas No. :35543-24-9

  Description: white lyophilized powder.
  Indication: 1. Peripheral vascular diseases, intermittent claudicating, Raynaud's syndrome, burger's syndrome, vascular spasm,
  2. Dizziness, tinnitus, hypophrenia, memory impairment, lack of concentration and impaired environmental interpretation induced by deficiency of  cerebral blood supply.
  Specification: 50mg/5ml
  Storage: protect from excessive light.

• CAS Registry Number:

  35543-24-9

• Synonyms:

  ;Buflomedil HCl;Buflomedil Hcl EP5;1-[4-oxo-4-(2,4,6-trimethoxyphenyl)butyl]pyrrolidinium chloride;4-cyclopentyl-1-(2,4,6-trimethoxyphenyl)butan-1-one hydrochloride (1:1);Buflomedil alkali;

• Molecular Formula:

  C₁₈H₂₇ClO₄

• Molecular Weight:

  342.85758

• Molecular Structure:

  

• Company:

  Shanghai DND Pharm-Technology Co., Inc.     [ China ]          

• Contact:

  Arron Yu

• Tel:

  021-58783620

• Fax:

  021-58783595

• Email:

  sales@dndpharm.com